BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 29250113)

  • 1. Encapsulation of Nicardipine Hydrochloride and Release from Biodegradable Poly(D,L-lactic-co-glycolic acid) Microparticles by Double Emulsion Process: Effect of Emulsion Stability and Different Parameters on Drug Entrapment.
    Soomherun N; Kreua-Ongarjnukool N; Chumnanvej S; Thumsing S
    Int J Biomater; 2017; 2017():1743765. PubMed ID: 29250113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the formulation of PLGA microparticles for controlled drug delivery.
    Lagreca E; Onesto V; Di Natale C; La Manna S; Netti PA; Vecchione R
    Prog Biomater; 2020 Dec; 9(4):153-174. PubMed ID: 33058072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(2-propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles as a targeted antigen delivery system to direct either CD4
    Yang L; Bracho-Sanchez E; Fernando LP; Lewis JS; Carstens MR; Duvall CL; Keselowsky BG
    Bioeng Transl Med; 2017 Jun; 2(2):202-211. PubMed ID: 29313030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Characterization of Critical Processing Parameters in the Fabrication of Double-Emulsion Poly(lactic-co-glycolic) Acid Microparticles.
    Bentley ER; Subick S; Pezzillo M; Balmert SC; Herbert A; Little SR
    Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release.
    Encinas-Basurto D; Konhilas JP; Polt R; Hay M; Mansour HM
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles.
    Lio D; Yeo D; Xu C
    Nanoscale Res Lett; 2016 Dec; 11(1):9. PubMed ID: 26745977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-Polymer Hybrid Nanoparticles Synthesized via Lipid-Based Surface Engineering for a robust drug delivery platform.
    Soomherun N; Kreua-Ongarjnukool N; Niyomthai ST; Chumnanvej S
    Colloids Surf B Biointerfaces; 2024 May; 237():113858. PubMed ID: 38547797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Different Factors on Poly(lactic-co-glycolic acid) Nanoparticle Properties and Drug Release Behaviors When Co-Loaded with Hydrophilic and Hydrophobic Drugs.
    Wang L; Wang P; Liu Y; Mustafa Mahayyudin MA; Li R; Zhang W; Zhan Y; Li Z
    Polymers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of technical and compositional variables on the size and release profile of bovine serum albumin from PLGA based particulate systems.
    Taghipour B; Yakhchali M; Haririan I; Tamaddon AM; Samani SM
    Res Pharm Sci; 2014; 9(6):407-20. PubMed ID: 26339256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of amphipathic lipopeptide-loaded PLGA microspheres as sustained-release system for AIDS prevention.
    Jin H; Chong H; Zhu Y; Zhang M; Li X; Bazybek N; Wei Y; Gong F; He Y; Ma G
    Eng Life Sci; 2020 Nov; 20(11):476-484. PubMed ID: 33204234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated experimental and modeling approach to propose biotinylated PLGA microparticles as versatile targeting vehicles for drug delivery.
    Donaldson O; Huang ZJ; Comolli N
    Prog Biomater; 2013 Feb; 2(1):3. PubMed ID: 29470678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Room Temperature Consolidation of a Porous Poly(lactic-co-glycolic acid) Matrix by the Addition of Maltose to the Water-in-Oil Emulsion.
    Esposito E; Ruggiero F; Vecchione R; Netti PA
    Materials (Basel); 2016 May; 9(6):. PubMed ID: 28773542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tunable Release of Curcumin with an In Silico-Supported Approach from Mixtures of Highly Porous PLGA Microparticles.
    Di Natale C; Onesto V; Lagreca E; Vecchione R; Netti PA
    Materials (Basel); 2020 Apr; 13(8):. PubMed ID: 32290458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable PLGA-Based Drug Delivery Systems for Modulating Ocular Surface Disease under Experimental Murine Dry Eye.
    Chang E; McClellan AJ; Farley WJ; Li DQ; Pflugfelder SC; De Paiva CS
    J Clin Exp Ophthalmol; 2011 Nov; 2(11):. PubMed ID: 23560247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(lactic-co-glycolic acid) Microparticles for the Delivery of Model Drug Compounds for Applications in Vascular Tissue Engineering.
    Wyse JM; Sullivan BA; Lopez P; Guda T; Rathbone CR; Wechsler ME
    Cells Tissues Organs; 2024 Jun; ():. PubMed ID: 38934132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new engineering process of biodegradable polymeric solid implants for ultra-long-acting drug delivery.
    Maturavongsadit P; Paravyan G; Kovarova M; Garcia JV; Benhabbour SR
    Int J Pharm X; 2021 Dec; 3():100068. PubMed ID: 33392498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA Core-Shell Nano/Microparticle Delivery System for Biomedical Application.
    Kim SM; Patel M; Patel R
    Polymers (Basel); 2021 Oct; 13(20):. PubMed ID: 34685230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrosprayed poly(lactic-co-glycolic acid) particles as a promising drug delivery system for the novel JNK inhibitor IQ-1.
    Kibler E; Lavrinenko A; Kolesnik I; Stankevich K; Bolbasov E; Kudryavtseva V; Leonov A; Schepetkin I; Khlebnikov A; Quinn MT; Tverdokhlebov S
    Eur Polym J; 2020 Mar; 127():. PubMed ID: 32372769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive Charge of "Sticky" Peptides and Proteins Impedes Release From Negatively Charged PLGA Matrices.
    Balmert SC; Zmolek AC; Glowacki AJ; Knab TD; Rothstein SN; Wokpetah JM; Fedorchak MV; Little SR
    J Mater Chem B; 2015 Jun; 3(23):4723-4734. PubMed ID: 26085928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Evaluation of PEG-Gelatin-Based Microparticles to Enhance the Oral Delivery of Insulin.
    Alfa J; Ben A; Buxaderas E; Akpa P; Hanifah A; Oseni OM; Kenechukwu FC; Momoh MA; Diaz DD
    Curr Pharm Des; 2024 Jun; ():. PubMed ID: 38847248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.